Back to Search
BETSE GAGE, M.D.
M.D.
Pediatrics Physician
NPI: 1801894258Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
R8D73(MO)0420438(KS)
Research & Publications (20)
Anemia: an independent predictor of death and hospitalizations among elderly patients with atrial fibrillation.
PMID 19464417·Am Heart J·2009
8-other
Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation.
PMID 19153410·Ann Intern Med·2009
5-case
Estimation of the warfarin dose with clinical and pharmacogenetic data.
PMID 19228618·N Engl J Med·2009
4-observational
Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score.
PMID 19332461·Circulation·2009
8-other
Interactive modeling for ongoing utility of pharmacogenetic diagnostic testing: application for warfarin therapy.
PMID 19679631·Clin Chem·2009
5-case
Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? Yes.
PMID 18627440·J Thromb Haemost·2008
6-review
Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin.
PMID 18281922·Genet Med·2008
4-observational
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.
PMID 18305455·Clin Pharmacol Ther·2008
8-other
Transitional sublethal and lethal effects of insecticides after dermal exposures to five economic species of wireworms (Coleoptera: Elateridae).
PMID 18459400·J Econ Entomol·2008
7-preclinical
Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients.
PMID 18662264·J Thromb Haemost·2008
4-observational
Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues.
PMID 17906972·J Thromb Thrombolysis·2008
6-review
Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose.
PMID 18480003·Am J Clin Pathol·2008
4-observational
Pharmacogenetic dose refinement prevents warfarin overdose in a patient who is highly warfarin-sensitive.
PMID 17944998·J Thromb Haemost·2008
5-case
Perspectives on the state-of-the-science in rehabilitation medicine and its implications for Medicare postacute care policies.
PMID 18047896·Arch Phys Med Rehabil·2007
6-review
Optimal initial dose adjustment of warfarin in orthopedic patients.
PMID 17911206·Ann Pharmacother·2007
8-other
Genetic-based dosing in orthopedic patients beginning warfarin therapy.
PMID 17387222·Blood·2007
3-trial
Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified?
PMID 17673721·Stroke·2007
8-other
Impact of drug coverage on medical expenditures among the elderly.
PMID 18624083·Health Care Financ Rev·2007
4-observational
Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital.
PMID 17238470·AMIA Annu Symp Proc·2006
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 21 N 12TH ST, SUITE 300
KANSAS CITY, KS 66102 - Phone
- (913) 342-2552
Quick Facts
- NPI
- 1801894258
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile